Genetic and Epigenetic Factors in Etiology of Diabetes Mellitus Type 1

Diabetes mellitus type 1 (T1D) is a complex disease resulting from the interplay of genetic, epigenetic, and environmental factors. Recent progress in understanding the genetic basis of T1D has resulted in an increased recognition of childhood diabetes heterogeneity. After the initial success of family-based linkage analyses, which uncovered the strong linkage and association between HLA gene variants and T1D, genome-wide association studies performed with high-density single-nucleotide polymorphism genotyping platforms provided evidence for a number of novel loci, although fine mapping and characterization of these new regions remains to be performed. T1D is one of the most heritable common diseases, and among autoimmune diseases it has the largest range of concordance rates in monozygotic twins. This fact, coupled with evidence of various epigenetic modifications of gene expression, provides convincing proof of the complex interplay between genetic and environmental factors. In T1D, epigenetic phenomena, such as DNA methylation, histone modifications, and microRNA dysregulation, have been associated with altered gene expression. Increasing epidemiologic and experimental evidence supports the role of genetic and epigenetic alterations in the etiopathology of diabetes. We discuss recent results related to the role of genetic and epigenetic factors involved in development of T1D.

[1]  N. Tandon.  Understanding type 1 diabetes through genetics: Advances and prospects , 2015, Indian journal of endocrinology and metabolism.

[2]  Leif Groop,et al.  Genetics of diabetes – Are we missing the genes or the disease? , 2014, Molecular and Cellular Endocrinology.

[3]  S. Purcell,et al.  Pleiotropy in complex traits: challenges and strategies , 2013, Nature Reviews Genetics.

[4]  A. Cooke,et al.  Type 1 diabetes: translating mechanistic observations into effective clinical outcomes , 2013, Nature Reviews Immunology.

[5]  B. Bader-Meunier,et al.  Mutation in the SLC29A3 Gene: A New Cause of a Monogenic, Autoinflammatory Condition , 2013, Pediatrics.

[6]  N J Cox,et al.  Genome wide association studies for diabetes: perspective on results and challenges , 2013, Pediatric diabetes.

[7]  Ben Lehner.  Genotype to phenotype: lessons from model organisms for human genetics , 2013, Nature Reviews Genetics.

[8]  R. Mallone,et al.  Insulin and type 1 diabetes: immune connections. , 2013, European journal of endocrinology.

[9]  Robert A. Martienssen,et al.  RNA interference in the nucleus: roles for small RNAs in transcription, epigenetics and beyond , 2013, Nature Reviews Genetics.

[10]  M. Rewers,et al.  Annals of the New York Academy of Sciences Pathogenesis of Type 1 Diabetes: Lessons from Natural History Studies of High-risk Individuals , 2022 .

[11]  Michael P Snyder,et al.  High-throughput sequencing for biology and medicine , 2013, Molecular systems biology.

[12]  Katarzyna A. Broniowska,et al.  Annals of the New York Academy of Sciences the Role of Reactive Oxygen Species and Proinflammatory Cytokines in Type 1 Diabetes Pathogenesis , 2022 .

[13]  T. Kieffer,et al.  Circulating miR-375 as a biomarker of β-cell death and diabetes in mice. , 2013, Endocrinology.

[14]  P. Pozzilli,et al.  Epigenetics in autoimmune diseases with focus on type 1 diabetes , 2013, Diabetes/metabolism research and reviews.

[15]  B. Bader-Meunier,et al.  Mutation in the SLC 29 A 3 Gene : A New Cause of a , 2013 .

[16]  D. Eizirik,et al.  Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation , 2013, Diabetologia.

[17]  R. Díaz,et al.  The role of nutrition on epigenetic modifications and their implications on health. , 2012, Biochimie.

[18]  A. Kuroda,et al.  Development of a Quantitative Methylation-Specific Polymerase Chain Reaction Method for Monitoring Beta Cell Death in Type 1 Diabetes , 2012, PloS one.

[19]  S. Sugihara.  Genetic susceptibility of childhood type 1 diabetes mellitus in Japan. , 2012, Pediatric endocrinology reviews : PER.

[20]  G. Nepom,et al.  A functional framework for interpretation of genetic associations in T1D. , 2012, Current opinion in immunology.

[21]  Mark Daly,et al.  What have we learned from six years of GWAS in autoimmune diseases, and what is next? , 2012, Current opinion in immunology.

[22]  L. Scott,et al.  What Will Diabetes Genomes Tell Us? , 2012, Current Diabetes Reports.

[23]  R. Regazzi,et al.  Emerging roles of non‐coding RNAs in pancreatic β‐cell function and dysfunction , 2012, Diabetes, obesity & metabolism.

[24]  G. Morahan.  Insights into type 1 diabetes provided by genetic analyses , 2012, Current opinion in endocrinology, diabetes, and obesity.

[25]  P. Hougaard,et al.  Circulating Levels of MicroRNA from Children with Newly Diagnosed Type 1 Diabetes and Healthy Controls: Evidence That miR-25 Associates to Residual Beta-Cell Function and Glycaemic Control during Disease Progression , 2012, Experimental diabetes research.

[26]  M. McCarthy,et al.  Association of the CpG Methylation Pattern of the Proximal Insulin Gene Promoter with Type 1 Diabetes , 2012, PloS one.

[27]  D. Leroith,et al.  The worldwide diabetes epidemic , 2012, Current opinion in endocrinology, diabetes, and obesity.

[28]  Zheng Liu,et al.  Profiles of Epigenetic Histone Post-translational Modifications at Type 1 Diabetes Susceptible Genes* , 2012, The Journal of Biological Chemistry.

[29]  Ping Yang,et al.  The Role of Endoplasmic Reticulum Stress in Autoimmune-Mediated Beta-Cell Destruction in Type 1 Diabetes , 2012, Experimental diabetes research.

[30]  A. Salvatoni,et al.  Enteroviruses and causality of type 1 diabetes: how close are we? , 2012, Pediatric diabetes.

[31]  L. Criswell,et al.  Emerging patterns of genetic overlap across autoimmune disorders , 2012, Genome Medicine.

[32]  N. Sarvetnick,et al.  Type 1 diabetes: role of intestinal microbiome in humans and mice , 2011, Annals of the New York Academy of Sciences.

[33]  H. Thomas,et al.  Intracellular pathways of pancreatic β‐cell apoptosis in type 1 diabetes , 2011, Diabetes/metabolism research and reviews.

[34]  F. Dotta,et al.  Increased expression of microRNA miR‐326 in type 1 diabetic patients with ongoing islet autoimmunity , 2011, Diabetes/metabolism research and reviews.

[35]  H. Hakonarson,et al.  Genome‐wide association studies (GWAS): impact on elucidating the aetiology of diabetes , 2011, Diabetes/metabolism research and reviews.

[36]  Constantin Polychronakos,et al.  A Genome-Wide Meta-Analysis of Six Type 1 Diabetes Cohorts Identifies Multiple Associated Loci , 2011, PLoS genetics.

[37]  Gregory P. Forlenza,et al.  The epidemic of type 1 diabetes: what is it telling us? , 2011, Current opinion in endocrinology, diabetes, and obesity.

[38]  Kasper Lage,et al.  Pervasive Sharing of Genetic Effects in Autoimmune Disease , 2011, PLoS genetics.

[39]  C. Carlson,et al.  Principles for the post-GWAS functional characterization of cancer risk loci , 2011, Nature Genetics.

[40]  R. Regazzi,et al.  Diabetes mellitus, a microRNA-related disease? , 2011, Translational research : the journal of laboratory and clinical medicine.

[41]  Nunzio Bottini,et al.  Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells. , 2011, Journal of medicinal chemistry.

[42]  N. Petrovsky,et al.  Alström syndrome: insights into the pathogenesis of metabolic disorders , 2011, Nature Reviews Endocrinology.

[43]  Thomas A. Down,et al.  Identification of Type 1 Diabetes–Associated DNA Methylation Variable Positions That Precede Disease Diagnosis , 2010, PLoS genetics.

[44]  J. Stockman,et al.  Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study , 2011 .

[45]  K. Zimmer,et al.  The subtle signs of Wolfram (DIDMOAD) syndrome: not all juvenile diabetes is type 1 diabetes , 2011, Journal of pediatric endocrinology & metabolism : JPEM.

[46]  M. Rewers,et al.  Rapid increase in the incidence of type 1 diabetes in Polish children from 1989 to 2004, and predictions for 2010 to 2025 , 2010, Diabetologia.

[47]  M. Pietropaolo,et al.  Type 1 diabetes: a genetic Pandora's box? , 2010, Pediatric diabetes.

[48]  C. Julier,et al.  Wolcott-Rallison syndrome , 2010, Orphanet journal of rare diseases.

[49]  I. Raz,et al.  Prevention of type 1 diabetes: today and tomorrow , 2010, Diabetes/metabolism research and reviews.

[50]  Edward Flynn,et al.  Overlapping genetic susceptibility variants between three autoimmune disorders: rheumatoid arthritis, type 1 diabetes and coeliac disease , 2010, Arthritis research & therapy.

[51]  J. Bluestone,et al.  IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells , 2010, The Journal of experimental medicine.

[52]  K. Stankov.  Genetic Predisposition for Type 1 Diabetes Mellitus - The Role of Endoplasmic Reticulum Stress in Human Disease Etiopathogenesis , 2010 .

[53]  John A. Todd,et al.  Genetics of Type 1 Diabetes: What's Next? , 2010, Diabetes.

[54]  Jason H. Moore,et al.  Missing heritability and strategies for finding the underlying causes of complex disease , 2010, Nature Reviews Genetics.

[55]  H. Hakonarson,et al.  Can the genetics of type 1 and type 2 diabetes shed light on the genetics of latent autoimmune diabetes in adults? , 2010, Endocrine reviews.

[56]  R. Uibo,et al.  The geoepidemiology of type 1 diabetes. , 2010, Autoimmunity reviews.

[57]  Sharath Kumar.  Wolfram syndrome: important implications for pediatricians and pediatric endocrinologists , 2010, Pediatric diabetes.

[58]  P. Meda,et al.  Involvement of MicroRNAs in the Cytotoxic Effects Exerted by Proinflammatory Cytokines on Pancreatic β-Cells , 2010, Diabetes.

[59]  Jason H. Moore,et al.  BIOINFORMATICS REVIEW , 2005 .

[60]  J. Michálek,et al.  microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients. , 2010, Cellular immunology.

[61]  Scott M. Williams,et al.  challenges for genome-wide association studies , 2010 .

[62]  Atul J. Butte,et al.  Autoimmune Disease Classification by Inverse Association with SNP Alleles , 2009, PLoS genetics.

[63]  K. Dietz,et al.  Epidemiological Perspectives on Type 1 Diabetes in Childhood and Adolescence in Germany , 2009, Diabetes Care.

[64]  A. Hattersley,et al.  The diagnosis and management of monogenic diabetes in children and adolescents , 2009, Pediatric diabetes.

[65]  A. Strom,et al.  Epigenetics: deciphering how environmental factors may modify autoimmune type 1 diabetes , 2009, Mammalian Genome.

[66]  D. Clayton.  Prediction and Interaction in Complex Disease Genetics: Experience in Type 1 Diabetes , 2009, PLoS genetics.

[67]  A. Green,et al.  Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study , 2009, The Lancet.

[68]  Helen Schuilenburg,et al.  Genome-wide association study and meta-analysis finds over 40 loci affect risk of type 1 diabetes , 2009, Nature Genetics.

[69]  J. Todd,et al.  Rare Variants of IFIH1, a Gene Implicated in Antiviral Responses, Protect Against Type 1 Diabetes , 2009, Science.

[70]  J. Todd,et al.  Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus , 2009, Genes and Immunity.

[71]  R. Hanås,et al.  A 2‐yr national population study of pediatric ketoacidosis in Sweden: predisposing conditions and insulin pump use , 2009, Pediatric diabetes.

[72]  Joseph T. Glessner,et al.  Follow-Up Analysis of Genome-Wide Association Data Identifies Novel Loci for Type 1 Diabetes , 2009, Diabetes.

[73]  M. Kanai,et al.  Rare Variants of IFIH 1 , a Gene Implicated in Antiviral Responses , Protect Against Type 1 Diabetes , 2009 .

[74]  A. Zhernakova,et al.  Detecting shared pathogenesis from the shared genetics of immune-related diseases , 2009, Nature Reviews Genetics.

[75]  A. Lemainque,et al.  WFS1 mutations are frequent monogenic causes of juvenile-onset diabetes mellitus in Lebanon. , 2008, Human molecular genetics.

[76]  Andrew Min,et al.  Lymphocytes From Patients With Type 1 Diabetes Display a Distinct Profile of Chromatin Histone H3 Lysine 9 Dimethylation , 2008, Diabetes.

[77]  T. Garrow,et al.  Type I diabetes leads to tissue-specific DNA hypomethylation in male rats. , 2008, The Journal of nutrition.

[78]  C. Polychronakos,et al.  The molecular genetics of type 1 diabetes: new genes and emerging mechanisms. , 2008, Trends in molecular medicine.

[79]  D. Clayton,et al.  PTPN22 Trp620 Explains the Association of Chromosome 1p13 With Type 1 Diabetes and Shows a Statistical Interaction With HLA Class II Genotypes , 2008, Diabetes.

[80]  J. Todd,et al.  HLA DR-DQ Haplotypes and Genotypes and Type 1 Diabetes Risk , 2008, Diabetes.

[81]  E. Jacobson,et al.  Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. , 2008, Endocrine reviews.

[82]  K. Mossman.  The Wellcome Trust Case Control Consortium, U.K. , 2008 .

[83]  Simon C. Potter,et al.  Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A , 2007, Nature.

[84]  Marian Rewers,et al.  The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes , 2007, Proceedings of the National Academy of Sciences.

[85]  R. A. Bailey,et al.  Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes , 2007, Nature Genetics.

[86]  P. Walter,et al.  Signal integration in the endoplasmic reticulum unfolded protein response , 2007, Nature Reviews Molecular Cell Biology.

[87]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[88]  J. Todd,et al.  The Type 1 Diabetes Genetics Consortium , 2006, Annals of the New York Academy of Sciences.

[89]  D. Ron,et al.  Endoplasmic reticulum stress signaling in disease. , 2006, Physiological reviews.

[90]  K. Gillespie.  Type 1 diabetes: pathogenesis and prevention , 2006, Canadian Medical Association Journal.

[91]  C. Julier,et al.  Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism , 2006, Nature Genetics.

[92]  P. Stern,et al.  In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes , 2006, Nature Genetics.

[93]  G. Lathrop,et al.  Wolcott-Rallison Syndrome: clinical, genetic, and functional study of EIF2AK3 mutations and suggestion of genetic heterogeneity. , 2004, Diabetes.

[94]  E. Hathout,et al.  Clinical, autoimmune, and HLA characteristics of children diagnosed with type 1 diabetes before 5 years of age. , 2003, Pediatrics.

[95]  H. Erlich,et al.  HLA-DQB1*0602 Is Associated With Dominant Protection From Diabetes Even Among Islet Cell Antibody–Positive First-Degree Relatives of Patients with IDDM , 1995, Diabetes.

[96]  Å. Lernmark,et al.  Effects of the second HLA-DQ haplotype on the association with childhood insulin-dependent diabetes mellitus. , 1995, Tissue antigens.